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Abstract
Background: Clostridium difficile infections (CDI) are a significant health problem to humans and food animals.
Clostridial toxins ToxA and ToxB encoded by genes tcdA and tcdB are located on a pathogenicity locus known
as the PaLoc and are the major virulence factors of C. difficile. While toxin-negative strains of C. difficile are
often isolated from faeces of animals and patients suffering from CDI, they are not considered to play a role
in disease. Toxin-negative strains of C. difficile have been used successfully to treat recurring CDI but their
propensity to acquire the PaLoc via lateral gene transfer and express clinically relevant levels of toxins has
reinforced the need to characterise them genetically. In addition, further studies that examine the pathogenic
potential of toxin-negative strains of C. difficile and the frequency by which toxin-negative strains may acquire
the PaLoc are needed.
Results: We undertook a comparative genomic analysis of five Australian toxin-negative isolates of C. difficile
that lack tcdA, tcdB and both binary toxin genes cdtA and cdtB that were recovered from humans and farm
animals with symptoms of gastrointestinal disease. Our analyses show that the five C. difficile isolates cluster
closely with virulent toxigenic strains of C. difficile belonging to the same sequence type (ST) and have
virulence gene profiles akin to those in toxigenic strains. Furthermore, phage acquisition appears to have
played a key role in the evolution of C. difficile.
Conclusions: Our results are consistent with the C. difficile global population structure comprising six clades
each containing both toxin-positive and toxin-negative strains. Our data also suggests that toxin-negative
strains of C. difficile encode a repertoire of putative virulence factors that are similar to those found in
toxigenic strains of C. difficile, raising the possibility that acquisition of PaLoc by toxin-negative strains poses
a threat to human health. Studies in appropriate animal models are needed to examine the pathogenic
potential of toxin-negative strains of C. difficile and to determine the frequency by which toxin-negative
strains may acquire the PaLoc.
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Background
Clostridium difficile is a Gram-positive pathogen that
has emerged to become one of the leading causes of in-
fectious diarrhoea in adult humans, securing its inclu-
sion in the ESCAPE group of pathogens [1–4]. C.
difficile infections range from being asymptomatic to
causing mild or severe diarrhoea and occasionally life-
threatening conditions such as pseudomembranous col-
itis and toxic megacolon [1, 5]. However, community-
acquired C. difficile infection is being reported with
increasing frequency [6] and C. difficile is also emerging
as a pathogen in animals particularly cattle, pigs and
horses [5, 7–10]. Molecular epidemiological studies
show that infections in humans and animals can share
the same ribotype or multilocus sequence type (ST) [11]
suggesting that pathogenic C. difficile may traffic
between humans and animals, although further studies
are needed to confirm these linkages.
C. difficile is a genetically diverse and globally dis-
persed species [11–16] having a clonal structure com-
prising six major clades (clades 1, 2, 3, 4, 5 and C-I).
Clade C-I is the most phylogenetically divergent clade
and may represent of a new subspecies of C. difficile
[17]. Clade C-I typically comprise toxin-negative strains
of C. difficile [17] but toxigenic variants that reside in
Clade C-I have recently been described [18]. Representa-
tives from most clades have been associated with CDI in
humans and comprise toxigenic strains with A+/B+, A−/B+
toxin types [11, 14, 17, 19–22]. Non-toxigenic strains of C.
difficile are represented in all six clades [11].
Toxin expression is considered mandatory for the de-
velopment of C. difficile disease [23, 24]. Two large clos-
tridial toxins known as toxins A (308 kDa) and B
(260 kDa) encoded by tcdA and tcdB and the genes im-
plicated in regulating their expression (tcdC, tcdE and
tcdR) reside on a 19.6-kb pathogenicity locus known as
the PaLoc [25, 26]. The PaLoc is replaced by 115/75 base
pair non-coding region in toxin negative strains of C.
difficile [27]. Approximately 20 % of C. difficile strains
express a third toxin, known as the binary toxin (CDT)
[28]. Genes encoding binary toxin (cdtA and cdtB) and a
regulator gene (cdtR) are usually located on a locus
(CdtLoc) that is physically separated from the PaLoc. A
recent study described six toxin-negative (A-/B-) isolates
of C. difficile that were positive for CDT from patient
with symptoms of CDI [28].
Assays that detect toxin genes or the products of their
expression dominate laboratory-based tests used to diag-
nose infections caused by C. difficile [29, 30]. Diagnostic
tests that target tcd genes underestimate the frequency
of detection of toxin-negative strains (including those
that express binary toxin) in C. difficile disease and as
such, their role in disease is poorly understood. Phylo-
genetic studies show that toxin-negative strains of C.
difficile cluster tightly with toxin-positive isolates be-
longing to the same ST [17] suggesting that presence
and absence of the PaLoc may be one of the major
defining features that differentiate toxin-negative strains
from toxin producing strains of C. difficile. Notably, oral
bacteriotherapy with toxin-negative strains or their
spores has been used successfully to treat patients
undergoing long-term antibiotic regimes and prevent
colonisation by toxigenic strains of C. difficile [31–33].
The utility of this therapeutic strategy is supported by
previous studies in hamsters which showed that expos-
ure of the gastrointestinal tract to toxin-negative C. diffi-
cile strains prevented colonisation by toxin-positive
strains [34, 35]. Interestingly, challenge studies in ham-
sters have shown that toxin-negative strains can effect-
ively colonise the gut [36, 37] suggesting that toxin
production may be of little consequence in determining
the success of colonisation of the gastrointestinal tract.
Notably, the toxin-negative strain CD1342 (tcdA−, tcdB−,
cdtA− and cdtB−) was reported to elicit an innate
immune response in the caecum resulting in neutrophil
infiltration, damage to epithelial mucosa and localised
haemorrhagic congestion [36]. These findings suggest
that virulence factors are carried by C. difficile in
addition to the known toxins that can induce host
pathology.
Studies of toxin-negative C. difficile strains have fo-
cused on the characterisation of functional binary
toxins and their roles in pathogenesis [28, 33, 38].
The binary toxins cdtA and cdtB have adenosine di-
phosphate ribosyltransferase activity but their capacity
to induce symptoms of C. difficile infection remains
unclear [39–42]. Several adhesins, ECM-binding pro-
teins, proteases, motility proteins, hydrolytic enzymes
and other surface-associated proteins have been de-
scribed in C. difficile and these factors are likely to
contribute significantly to the establishment, progres-
sion and severity of C. difficile disease [11, 43].
Therefore, further studies are needed to examine the
pathogenic potential of toxin-negative strains of C.
difficile and to determine the frequency at which
toxin-negative strains may acquire the PaLoc and ex-
press toxins.
Studies that seek to understand the evolutionary his-
tory of the PaLoc highlight the complex nature of the
multiple clade-specific acquisitions that have occurred
after clonal expansion of each clade in populations of C.
difficile [17]. Those studies report homologous and site-
specific recombination events as having played an im-
portant role in the loss and gain of the PaLoc [17]. The
PaLoc is proposed to be a mobile element that can
transfer to toxin-negative strains rendering the recipient
with the ability to produce clinically relevant concentra-
tions of ToxA and ToxB [44]. Toxin-negative strains are
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purported to be ancestral to modern C. difficile but lat-
eral genetic events complicate phylogenetic interpret-
ation and alternate hypotheses have been proposed [17].
Genomic studies incorporating a greater diversity of
toxin-negative strains of C. difficile are needed to shed
light on their potential to cause disease.
Methods
Isolation and culture of Clostridium difficile
All C. difficile isolates analysed in this study (P29, 5.3,
19.3, 22.1, H3) were obtained from watery diarrhoea
stool samples from their respective hosts (Additional file
1: Table S1). The porcine and equine C. difficile isolates
analysed in this study were sourced in 2008 from differ-
ent geographical locations in New South Wales,
Australia. The porcine isolate P29 was isolated from a
stool sample submitted by the veterinarian attending a
piglet with severe but non-fatal diarrhoea. The equine
isolate H3 was isolated from a live neonatal foal suffer-
ing from non-fatal watery diarrhoea. Stool samples were
tested with PCR targeting major ETEC virulence genes
[45] and common viruses known to cause diarrhoea in
neonatal animals and were plated on blood agar plates
to select for enteric pathogens. The stool specimens
were initially tested for Escherichia coli, Clostridium
perfringens and C. difficile using species-specific PCR
primers [46]. Briefly, DNA was extracted from 500 μl of
stool sample using a FastDNA spin kit (QBiogene,
California, USA) and used as a template for PCR using
primers specific for C. difficile and C. perfringens 16S
rDNA [46], tcdA and tcdB genes (see below) and for E.
coli [45]. To enrich for C. difficile 100 μl of each faecal
sample was added to 10 ml cooked meat medium
(TM0102 Oxoid Australia) and incubated anaerobically
at 37 °C for 24 h using the anoxomat system (MART
Microbiology B.B., The Netherlands).
Two hundred μl of culture samples that tested positive
for C. difficile by PCR were transferred (from cooked
meat media enrichment broth) into an Eppendorf tube
and centrifuged (10,000 rpm, 5 min). The pellet was
resuspended in 1 ml of absolute ethanol (room
temperature, 2 h with periodic inversions), harvested by
centrifugation (10,000 rpm, 5 min), resuspended in brain
heart infusion broth (100 μl) and plated onto C. difficile
selective agar (CC-BHIA + Taurocholate, PP2362 Oxoid
Australia). Plates were incubated under anaerobic condi-
tions at 37 °C for 24 h. Colonies morphologically repre-
senting C. difficile from each plate were selected and
sub-cultured onto CC-BHIA + Taurocholate until pure
cultures were achieved.
DNA extraction
For routine PCR, template DNA was extracted with
Chelex (BIO-RAD) from 2 ml brain heart infusion broth
cultures grown under anaerobic conditions at 37 °C for
48 h. Briefly, cell pellets were obtained by centrifuging
(10,000 rpm for 5 min) 200 μl aliquots of liquid culture,
washed 2 × with 500 μl of sterile water and resuspended in
200 μl of 6 % Chelex solution made in Tris-EDTA buffer
(pH 7.5). The samples were incubated at 56 °C for 20 min,
vortexed for 10 s and incubated at 100 °C for 8 min. After
incubation, the sample was immediately transferred to ice.
One aliquot was stored at 4 °C for routine PCR tests while
the other aliquots were archived at −20 °C.
Sequencing-quality genomic DNA was prepared from
2 ml brain heart infusion broth culture of isolates grown
under anaerobic conditions at 37 °C for 48 h. The over-
night culture was harvested by centrifugation
(10,000 rpm for 10 min), washed in sterile PBS and re-
suspended in 180 μl of lysis buffer comprising
20 mM Tris-HCl, pH 8.0, 2 mM EDTA, 1.2 % Triton
X-100 and lysozyme (20 mg ml−1) and incubated for
45 min at 37 °C. DNA was isolated using a DNeasy®
Blood and Tissue Kit (Qiagen) by adhering to the
manufacturer’s instructions for the extraction of DNA
from Gram-positive bacteria.
PCR conditions
C. difficile specific 16S rDNA primers, C.diff-F: 5′-
TTGAGCGATTTACTTCGGTAAAGA-3′ and C.diff-R:
5′-CCATCCTGTACTGGCTCACCT-3′ were used for
identification and confirmation of C. difficile in enrich-
ment as well as pure cultures. The presence of the tpi
gene (encoding Triose Phosphate Isomerase), tcdA gene
(encoding Toxin A) and tcdB gene (encoding Toxin B)
were tested using previously published primer pairs. Con-
ditions for PCR were as described previously [22] with
minor modifications. Briefly, PCR was carried out in 25 μl
volumes containing 2 μl of Chelex extracted DNA, 2.5 μl
of 10 × PCR buffer, 1.5 mM of MgCl2, 1 mM of each
dATP, dGTP, dCTP and dDTP (Bioline, Australia), 0.5 μM
of each primer and 1 U of BioRad Taq polymerase (Bio-
line, Australia). PCR cycling conditions consisted of an
initial denaturation cycle (2 min, 95 °C) followed by 30 cy-
cles of denaturation (94 °C, 1 min), annealing (55 °C,
1 min) and extension (72 °C, 2 min). The cycling process
was completed with a final extension of 72 °C for 5 min.
Whole genome sequencing, data assembly and
phylogenetic analysis
Sequencing was performed at the Next Generation
Sequencing facility within the ithree institute at the Univer-
sity of Technology Sydney using a bench top IlluminaMiSeq®
sequencer and MiSeq V3 chemistry. Genomic DNA stocks
shipped to the sequencing facility at concentrations between
1.8 and of 3.7 ng μl−1 were used as template for the prepar-
ation of sequencing libraries. The genomes were sequenced
and assembled de novo using published protocols [47]. Raw
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data and assembled genome sequences were submitted in
GenBank under the following Bio-project numbers, 5.3:
PRJNA232267, 19.3: PRJNA239262, 22.1: PRJNA239264,
P29: PRJNA239265 andH3: PRJNA238844.
PhyloSift was used to conduct a phylogenetic analysis
of the five C. difficile genomes (P29, 5.3, 19.3, 22.1, H3)
with nine closed C. difficile genomes including strains
M120, CF5, M68, 2007855, BI1, CD196, R20291,
ATCC43255 and CD630 available in the NCBI genome
database on the 18th of December 2014 [48]. FigTree
version 1.4.0 (http://tree.bio.ed.ac.uk/software/figtree/)
was used to draw phylogenetic trees. Genome sequences
of C. perfringens (ATCC13124), Clostridium botulinum
(ATCC19397) and Clostridium tetani (E88) were in-
cluded as outgroups in the analysis. To improve visual
resolution of the evolutionary distances between test and
reference strains of C. difficile the final figure was gener-
ated without the out-groups.
For reference-genome based phylogenetic inference,
raw Illumina reads from all taxa were mapped to a single
reference (strain CD630) using BWA-MEM (ver0.7.9a)
(Li unpublished, github commit: 3efc33160c) and con-
sensus sequences generated using the samtools/bcftools
(ver0.1.19-96b5f2294a) tool-chain [49]. The complete set
of consensus sequences were combined into a multiple
sequence alignment. 1,216,986 alignment columns con-
taining unresolved nucleotides (N) were removed using
Mothur (ver1.33.3) [50]. A total of 3,073,266 (72 %)
polymorphic and non-polymorphic sites were retained
for further analysis. The inclusion of invariant sites has
been demonstrated to improve accuracy of whole gen-
ome phylogeny [51]. Maximum likelihood phylogenetic
inference was employed using RAxML (ver8.0.20) [52]
with the following options: raxmlHPC-PTHREADS-
SSE3 -T 40 -f a -x 2136841 -p 1486312 -N autoMRE -m
GTRCAT. Inference was carried out under a general
time reversible (GTR) substitution model with an infin-
ite mixture model for substitutional heterogeneity
(CAT), following the suggestion of the RAxML user
guide for datasets of this size. The CAT approximation
has been previously demonstrated to be an accurate and
highly efficient alternative to Gamma-distributed rate
heterogeneity on data sets with many taxa (73 – 1663)
[53, 54]. Confidence in each clade of the Maximum Likeli-
hood tree was estimated using the rapid bootstrap proced-
ure [55] with automatic extended majority-rule criterion
(100 bootstraps) and the resulting tree and bootstrap con-
fidence estimates were visualized with FigTree version
1.4.0 (http://tree.bio.ed.ac.uk/software/figtree/).
Multi locus sequence typing and comparative genomic
analysis
The online version of C. difficile PubMLST database
(http://pubmlst.org/cdifficile/) was used to sequence
type the isolates from the assembled genome sequences.
The database was also exploited to locate certain genes
of interest.
The online version of the RAST annotation server
(http://rast.nmpdr.org/) [56] was used to annotate the
genomes. The Classic RAST annotation scheme and Fig-
FAM release 70 were used to predict genes (5.3 = RAST-
ID 6666666.71923, 19.3 = RAST-ID 6666666.71924, H3
= RAST-ID 6666666.72094, P29 = RAST-ID 1440056.4
and 22.1 = RAST-ID 6666666.72093). Amino acid se-
quences corresponding to translated peptide products of
all open reading frames predicted by RAST [57] from
each of the five genomes were used in the ‘all Vs all’
homology search protocol deposited in the github re-
pository as cRBLH (https://github.com/cerebis/crblh/
tree/v0.1). The protocol included clustering of predicted
peptide sequences using a modified reciprocal best hit
method, where simplicity was favoured for the apparent
advantage in identifying orthogroups [58]. The all vs. all
homology search was carried out with LAST [59–61]
using runtime parameters (−T 1 -f 0 -e 100). The best
hits were used to generate a directed graph with genes
as vertices and best hits as edges. Unidirectional links
between any two nodes were then pruned. Sets of
disconnected subgraphs were then analysed for weak
intra-cluster linkages, which likely represented overlap
between partially homologous protein clusters. Each
subgraph was subjected to modularity optimisation [62]
and further decomposed until modularity scores of
constituent elements fell below a given threshold
(0.2). The nodes of the resulting subgraphs were then
written out as protein clusters. Singletons defined as
nodes without a single edge to any other were
deemed unique/isolated genes.
Whole genome comparisons were performed using
Mauve version 2.3.1 [63, 64] and iterative BLASTn ana-
lysis (http://blast.ncbi.nlm.nih.gov/Blast.cgi). Inter-isolate
regions of interest identified from genome-wide compar-
isons using Mauve, BLASTp and protein clustering ana-
lyses were analysed further using iterative BLASTn and
BLASTp searches. Figures of comparative genomic ana-
lysis, including comparisons of the PaLoc, were com-
piled using locally downloaded version of EasyFig
version 2.1 [65].
The genome of the epidemic C. difficile CD630
strain was used in whole genome BLASTp analysis
(in RAST) with our test C. difficile genomes to iden-
tify genes that have been correlated with pathogen-
icity. All genes deemed as candidate alternative
virulence genes or genes for which the products could
potentially confer pathogenic traits were individually
interrogated using BLASTp and setting amino acid
alignment cut off set to 100 % of input query se-
quence to avoid any data extrapolation.
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Results
Toxin-negative C. difficile from animals and humans with
clinical disease
The original stool samples and primary enrichment cul-
tures of the stool samples tested negative for C. difficile
toxins A and B. PCR assays using DNA from enrichment
broths tested negative for enteric (other than C. difficile)
and viral pathogens associated with neonatal diarrhoea.
The porcine faecal sample was negative for the entero-
toxigenic E. coli genes STa, STb and LT and C. perfrin-
gens and the disease symptomology did not correlate
with viral disease as diagnosed by the attending veterin-
arian. Similarly, the foal sample was tested for E. coli,
Salmonella enterica and rotavirus and none were de-
tected. While gastrointestinal disease was most likely as-
sociated with the presence of toxin-negative C. difficile
we cannot rule out the possibility that disease was
caused by unculturable/unknown pathogens present in
the gastrointestinal tract of these animals. Toxin-
negative human C. difficile isolates 5.3, 19.3 and 22.1
were collected in the course of routine diagnostic tests
for C. difficile-associated diarrhoea in patients presenting
typical symptoms of the disease at a gastrointestinal
clinic in Sydney, Australia in 2008.
Interrogation of the C. difficile PubMLST database
confirmed that none of the toxin-negative isolates in our
cohort (P29, H3, 5.3, 19.3, 22.1) had homologs of the
known C. difficile PubMLST toxin genes (tcdA, tcdB,
cdtA and cdtB) confirming our initial diagnostic PCR
data for toxin A and B genes (Additional file 1: Table
S1). Isolates 5.3 (ST15), P29 (ST109) and H3 (ST29)
were distinct from each other and from ST types of
Australian isolates included in a recent phylogenetic
study of C. difficile (Additional file 1: Table S1) [17].
Phylogenetic analysis of toxin-negative isolates of C.
difficile
A study of the evolution of the C difficile pathogenicity
locus (PaLoc) identified an extremely divergent clade
C-I that exclusively comprised toxin-negative isolates
predominantly of Australian origin [17]. A maximum-
likelihood phylogenetic tree using a reference-based,
whole genome alignment protocol (see methods sec-
tion for protocol details) that incorporates both variant
and invariant sites of the C. difficile genome sequences
was used to verify the ancestry of our toxin-negative
isolates. Our approach uses approximately 72 % of the
C. difficile genome for the analysis, considerably more
than what was used in the original study [17]. All 73
genomes and the reference genome CD630 used in the
previous study [17] as well as additional closed ge-
nomes of C. difficile (strains 2007855, ATCC43255,
BI1, CF5, M68, M120 and R20291 from the GenBank
database) were used in our initial phylogenetic
analysis. A preliminary phylogenetic tree (Additional
file 2: Figure S12) revealed that our genome-based
phylogeny was largely congruent with that described in
an earlier study [11] and clearly indicated that none of
the five genomes that were the subject of our study
clustered within the divergent clade C-I.
Strains that resided within clade C-I showed greater
than 5 % sequence divergence from the reference gen-
ome at homologous sites. Clades that have diverged
more than 5 % from the reference genome can be poorly
resolved in workflows based on Illumina read mapping
to the reference [51]. Given this and the uncertain an-
cestry of the isolates included in clade C-I in the Dingle
et al. [11] study, members of clade C-I were excluded
from the subsequent analysis based on a cohort of 86
strains depicted in Fig. 1. The branching order of the five
clades in our phylogenetic tree was congruent with that
reported earlier [17] with identical clustering of strains
in the different sub-clades within each of the five clades.
The five toxin-negative isolates from our study clustered
with strains in Clades 1 (C. difficile 5.3, and H3) and 4
(C. difficile 19.3, 22.1 and P29) that are known to con-
tain toxin-negative strains [17]. Our toxin-negative iso-
lates (sourced both from animal and human sources)
also clustered with strains of the same sequence type
that included both toxin-positive and toxin-negative
strains isolated from human clinical specimens in an
earlier study [17].
Our genome sequences were assembled with a de novo
assembler using A5 [48]. Prior to conducting a detailed
analysis of the toxin-negative C. difficile isolates we iden-
tified the closest reference genome for tiling genomic
scaffolds. A preliminary phylogeny generated using
PhyloSift and FastTree (Additional file 2: Figure S2) indi-
cated that C. difficile strain CF5 (toxin-positive ST86)
was the most appropriate reference to order genomic
scaffolds of isolates 19.3 (ST39), 22.1 (ST39) and P29
(ST109) while C. difficile strain 630 (toxin-positive, ST54
(PCR ribotype 012) was appropriate to order genomic
scaffolds of isolates 5.3 (ST15) and H3 (ST29). Strain
CF5 was isolated from a patient in Belgium in 1995
while CD630 is a highly virulent, multiple antibiotic re-
sistant strain of C. difficile that caused pseudomembran-
ous colitis in a human patient and later caused an
epidemic of C. difficile infection in a Swiss hospital ward
in 1982. All down-stream analyses of the genomes
presented in this study were performed on genomic as-
semblies with scaffolds ordered to match the reference
genomes.
Homology based functional similarity in the toxin-
negative isolates
Initially a Progressive Mauve alignment performed
(Additional file 2: Figure S3) on genome sequences of
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human ST39 isolates 19.3 and 22.1 revealed a high
level of nucleotide identity across the genomes with
324 SNP differences. Most of the SNPs were clustered
into 7 groups (see Additional file 3: Table S4) sug-
gesting that lateral gene transfer or homologous
recombination-mediated genomic rearrangements may
be responsible for the differences and were not con-
sidered further. Only 27 SNPs were identified that
could generate changes in the amino acid sequence of
the predicted proteins in the table Additional file 3:
Table S4.
To identify genes affected by the SNP changes, a bi-
directional BLASTp comparison of 3772 proteins com-
prising the predicted proteome of strain 19.3 was per-
formed with 3764 predicted protein sequences from
strain 22.1 in RAST. The analysis identified 3750 protein
sequences that were identical in both the genomes. Nine
protein sequences had greater than 99 % sequence iden-
tity, six others had greater than 97 % sequence identity
and one ORF encoding a hypothetical protein showed
49 % sequence identity (Additional file 3: Table S5). Pro-
teins sharing 97 and 99 % sequence identity predomin-
antly encoded components of the bacterial cell surface
including N-acetylmuramoyl-L-alanine amidase, flagellar
assembly protein FliH, lipoprotein signal peptidase, pu-
tative ABC transporters and permeases. Eight ORFs in
isolate 19.3 predominantly encoding hypothetical pro-
teins were missing in isolate 22.1. The genomes of iso-
lates 19.3 and 22.1 comprise 4,181,809 and 4,180,898 bp
respectively.
Since isolates 22.1 and 19.3 had high levels of hom-
ology, predicted proteins only from isolate 19.3 were in-
cluded in a pairwise bi-directional BLASTp analysis that
seeks to identify conserved genes and major differences
among toxin-negative isolates of Australian origin.
Isolate P29 had the largest predicted proteome in our
collection and was used as the reference. Comparisons
of predicted proteomes of human isolates 5.3 & 19.3 and
equine isolate H3 with P29 identified major differences
in regions harbouring prophage-associated proteins,
hypothetical proteins (Additional file 3: Table S5) and
putative transposases associated with mobile genetic
elements.
Chromosomal context of the PaLoc insertion site
In toxin-negative strains, a 115 bp sequence replaces the
PaLoc locus in phylogenetic clades 1 and 4 and the gen-
etic context in which the 115 bp sequence resides varies
within the different clades that represent the C. difficile
population structure [17]. An analysis of the genetic
context of the 115 bp sequence in our toxin-negative
isolates compared to GenBank sequence entries repre-
senting chromosomal regions adjacent to the PaLoc
insertion site in toxin-negative strains belonging to
Fig. 1 A midpoint rooted phylogenetic tree depicting the five C.
difficile clades. Australian toxin-negative strains are identified with blue
strain names. Complete, closed genomes available in GenBank that
were used as a reference are in green text. Genome names in black
text are from a previous study [20]. The tree was constructed from
reference-based whole genome alignments. Strains within boxed
regions indicate genomes used in the ALL vs ALL BLASTp analysis.
Clades highlighted in blue indicate clade 4 and in aqua is clade 1
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Clades 1 (GenBank Accession no HG002393) and 4
(GenBank Accession no HG002391) is depicted in Fig. 2.
We identified several SNPs within the 115 bp-conserved
fragment and an 80 nt long insertion in strains 5.3 and
H3 downstream of the gene designated CD06642 in the
reference genomes (Fig. 2). In addition, we identified a
68 nt tandem repeat of the sequence adjacent to the
80 nt insertion site in strain H3 (see Additional file 2:
Figure S7). Within members of clade 4, porcine isolate
P29 had a deletion of the hypothetical gene seen in the
reference region while human isolates 19.3 and 22.1 had
a significant decrease in the nucleotide identity in hypo-
thetical genes in the reference genome. Consistent with
observations reported earlier, these differences indicate
ongoing micro-evolutionary events within the locus that
flanks the PaLoc insertion site [17].
Comparative BLASTp analyses of toxin-negative strains to
identify functional similarities between groups of isolates
An all versus all BLASTp based protein-clustering ana-
lysis was used to identify the putative core proteome of
a subset of Clade 1 strains comprising five genomes and
Clade 4 strains comprising 10 genomes (see boxed re-
gion in Fig. 1). To maintain uniformity in the input data
used in the analysis, raw reads representing each of the
genomes from an earlier study [17] were reassembled
and annotated using the protocols that were used to as-
semble and annotate the five toxin-negative Australian
isolates of C. difficile reported in this study, as described
above. The assembly statistics and a comparison of the
assembly outputs are presented in Additional file 3:
Table S8. On an average, RAST predicted 3700 proteins
per genome and these were included in the protein
Fig. 2 Genetic context of the PaLoc in Australian toxin-negative strains of C. difficile. a Clade 1 prototype OxI_WB2011 (HG002393). b Clade 4
prototype Oxa464a (HG002391)
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clustering analysis. A bit score cut off of 50 was used to
cluster homologous protein sequences. An overview of
the data is presented in Table 1.
Ten clade 4 genomes boxed in Fig. 1 shared 3357 pro-
teins (Table 1). Isolate P29 had the highest number (299)
of unshared/unique proteins within the clade 4 cohort
and most of the 299 proteins were phage-related
(Additional file 3: Table S9). Some of the unique pro-
teins clustered together in the same scaffold indicat-
ing lateral movement of phage-associated genomic
DNA. C. difficile isolates 19.3 and 22.1 carried eight
and seven unique proteins respectively. The handful
of unshared proteins in 19.3 and 22.1 were attributed
to mobile genetic elements or were designated to en-
code proteins of unknown function. The five C. difficile
strains within clade 1 shared 3323 proteins. Equine isolate
H3 had 111 unique proteins, most of which were phage
related or hypothetical with some clustered in single scaf-
folds (Additional file 3: Table S9).
We queried the viral and prophage database in Gen-
Bank with the genome sequences of all five toxin-
negative isolates using PHAST [66]. The database con-
firmed the presence of several regions contain phage
DNA in each of the five genomes in Clade 1 (see Add-
itional file 2: Figure S10 and Additional file 4: Table
S11). Table 2 lists a summary of the complete prophage
sequences (PHAST scores > 110 and over) identified in
the five Australian toxin-negative isolates. Notably,
isolates 19.3 and 22.1 returned identical phage profiles
(Additional file 2: Figure S10). Both genomes carried an
identical and complete 56.8 kb phage that is a close rela-
tive of phiC2, a 56.5 kb phage first identified in C. diffi-
cile strain CD242 [67]. phiC2 is one of the first
completely sequenced temperate phages in C. difficile
and regions of phiC2 are present in the majority of C.
difficile genomes of clinical origin [68]. We also identified
a phage in isolates P29 and H3 that carries sequence
identity with phiC2. The prophage in P29 was larger
(97.4 kb) than the original phiC2 sequence (Additional
file 2: Figure S10). Isolate P29 also carries two other
complete prophage sequences. One of these, prophage
region 9 has significant sequence identity to the C. diffi-
cile temperate bacteriophage phiCD6356 that belongs to
the Siphoviridae family [69]. The Siphoviridae family pro-
phage identified in P29 is 52.8 kb (Additional file 4:
Table S11) and is considerably larger than the first report
of this phage sequence at 37.6 kb [69]. Isolate H3 also
carries an identical variant of phage phiCD6356 (Add-
itional file 2: Figure S12) comprising 41.1 kb. Evidence of
other complete prophage genomes is listed in Table 2.
Comparative BLASTp analysis of the four genomes (19.3,
5.3, H3 and P29) also aligned to the phage search proto-
col and confirmed the data generated by PHAST ana-
lyses, reinforcing the observation that the major
differences in our Australian toxin-negative C. difficile
isolates have a prophage origin.
Comparative BLASTp analysis of isolates 19.3, 5.3, H3
and P29 identified a 119.3 kb region on contig 11 in P29
(Additional file 5: Table S6). An all versus all protein
clustering analysis also identified a subset of unique pro-
teins on contig 11 of the P29 genome but not in the 10
human C. difficile genomes within clade 4 (Fig. 1).
Equine isolate H3 was not included in this analysis as it
was on a different clade. BLASTn analysis of the
119.3 kb region against the C. difficile genome database
in GenBank identified similarity at the DNA level to
parts of C. difficile strain CD630 indicating a phage-
mediated lateral movement of parts of the genome of
CD630 into the genomes of isolates H3 and P29.
Homology based functional prediction of Putative C.
difficile virulence factors implicated in host colonization
A homology-based functional prediction analysis of pro-
teins that have been experimentally verified, or predicted
to play a role in the colonization of C. difficile strain
CD630 with homologous proteins in the genomes of the
toxin-negative isolates in our study is shown in Table 3
Table 1 Summary of protein clustering results within the
different sub-clades containing the five toxin negative isolates
included in this study. Summary of protein clusters within the
different sub-clades of C. difficile
Clade 1
Genome names No of predicted proteins
Core genome 3323
Total number of unique peptides in:
C. difficile C0000509 45
C. difficile C0000541 38
C. difficile C0000562 176
C. difficile C00005945 212
C. difficile H3 111
Clade 4:
Core genome 3357
Total number of unique peptides in:
C. difficile 19.3 8
C. difficile 22.1 7
C. difficile C00000089 33
C. difficile C000011286 86
C. difficile C00006473 84
C. difficile C00007671 35
C. difficile C00011267 60
C. difficile CF5 30
C. difficile M68 19
C. difficile P29 299
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[70, 71]. Most of the proteins i had near perfect (98–
100 %) protein sequence identity including proteins
encoded by spo0A, which serves as a positive regula-
tor for genes required in spore germination and
groEL, a chaperone that also functions as an adhesin
[72]. Several serine-proteases and other metallopro-
teases which may contribute to the disease develop-
ment process [70] were also highly conserved.
However, some membrane associated proteins that
have been shown to play significant roles in the dis-
ease development process had lower alignment
scores including SlpA, a surface layer protein that is
proposed to facilitate host cell adherence [73] and
FliC, an adhesin necessary for the colonization of
gut epithelium [74].
Discussion
C. difficile colonisation in humans is age dependent.
While asymptomatic carriage is common in infants less
than three years of age it is rare in adults [75]. As such,
infants can be a major reservoir of both pathogenic and
toxin-negative strains in a community setting [75]. We
isolated five toxin-negative isolates of C. difficile includ-
ing three from humans (22.1, 19.3, 5.3), one from a pig
(P29) and one (H3) from a horse all showing symptoms
of gastrointestinal disease. Despite efforts to identify C.
difficile toxin genes or toxin gene products in the stool
samples during the course of the isolation of these
strains, none were detected. Phylogenetic studies showed
that human ST39 isolates 19.3 and 22.1 and porcine
ST109 isolate P29 grouped with clinical human toxigenic
strains of ST39 and ST109 respectively in Clade 4.
Furthermore, human ST15 isolate 5.3 and equine ST29
isolate H3 grouped with human clinical toxigenic strains
with ST15 and ST29 respectively in Clade 1. Compara-
tive genome analyses showed that our toxin-negative
isolates displayed virulence gene profiles akin to those
identified in toxigenic strains. The animals from which
samples were collected in this study exhibited gastro-
intestinal disease and we were unable to attribute these
symptoms to the presence of toxin-positive strains of C.
difficile. Given the mobility of the PaLoc [44] and evi-
dence that the acquisition or loss of the PaLoc via
recombination [17] has occurred multiple times dur-
ing the evolution of the five major clades of C. diffi-
cile [11, 17], our data reinforces calls to include
toxin-negative strains in genomic epidemiological
studies of C. difficile [17, 36] and to better character-
ise asymptomatic carriage of closely related Clostridia
in gut microbiome surveys such as the Human
Microbiome Project and MetaHIT, both in humans
and close animal contacts.
Our reference-based whole genome alignment and
phylogeny analyses support the global population struc-
ture of C. difficile as described by Dingle et al. in 2014
[14, 17, 19]. Each clade has been shown previously to
have representatives of both toxin-positive and toxin-
negative strains [11]. Our toxin-negative isolates (19.3,
22.1, 5.3, P29, H3) belonged to STs that are distinct from
those reported in an earlier study [17]. The role of toxins















C difficile P29 genome
Region_4 97.4Kb 150 126 1732045-1829500 PHAGE_Clostr_CDMH1_NC_024144 28.7 27.1, 30.1, 40.1, 34.1, 36,1,
5.1, 47.1 and 16.1
Region_8 113.6Kb 150 101 3773336-3886941 PHAGE_Geobac_virus_E2_NC_009552 40.8 5.1, 19.1 and 22.1
Region_9 52.8Kb 140 65 4233532-4286418 PHAGE_Clostr_phiCD6356_NC_015262 29.9 8.1, 26.1, 41.1 and 42.1
Region_10 21.3Kb 100 22 4290994-4312349 PHAGE_Clostr_phiC2_NC_009231 36.4 In over 20 very small
scaffolds
C. difficile H3 genome
Region_2 41.1Kb 150 63 925289-966449 PHAGE_Clostr_phiCD6356_NC_015262 28.5 22.1 and 31.1
Region_3 50.1Kb 110 66 1114600-1164714 PHAGE_Clostr_phiC2_NC_009231 28.1 18.1 and 5.1
Region_6 31.5Kb 110 47 4070500-4102080 PHAGE_Clostr_phiC2_NC_009231 29.4 26.1, 27.1, 28.1, 32.1, 33.1
C. difficile 5.3 genome
Region_3 57.9Kb 140 87 1555612-1613526 PHAGE_Clostr_phiC2_NC_009231 28.6 1.1
Region_4 45.1Kb 150 49 1741883-1787019 PHAGE_Clostr_phiSM101_NC_008265 27.2 1.1
C.difficle 19.3 genome
Region_3 56.8Kb 140 74 1700180-1757059 PHAGE_Clostr_phiC2_NC_009231 28.8 1.1
C. difficile 22.1 genome:
Region_3 56.8Kb 140 74 1703858-1760737 PHAGE_Clostr_phiC2_NC_009231 28.8 3.1
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Table 3 Proteins derived from C. difficile CD630 that are predicted to play a role in pathogenesis





In C. difficile 5.3 (% identity) In C. difficile 19.3 (% identity) In C. difficile H3 (% identity) In Cc difficile P29 (% identity)
Flagellin C gene fliC CD630_02390 yes, RNAseq fig|6666666.71923.peg.3142 (86) fig|6666666.71924.peg.3067 (71)* fig|6666666.72094.peg.3176 (87) fig|1440056.4.peg.3191 (97)
Flagellin D gene fliD CD630_02370 no fig|6666666.71923.peg.3140 (88) fig|6666666.71924.peg.3065 (61) fig|6666666.72094.peg.3174 (88) fig|1440056.4.peg.3193 (98)
Precursor S-layer protein gene slpA CD630_27930 yes, proteome fig|6666666.71923.peg.2081 (43)* fig|6666666.71924.peg.3725 (59) * fig|6666666.72094.peg.2466 (58)* fig|1440056.4.peg.2665 (54)*
Stage 0 Sporulation gene spoA CD630_12140 yes, proteome fig|6666666.71923.peg.158 (100) fig|6666666.71924.peg.1561 (99) fig|6666666.72094.peg.2932 (99) fig|1440056.4.peg.240 (99)
Fibrinectin binding proten encoding
fbpA gene
CD630_25920 no fig|6666666.71923.peg.2930 (99) fig|6666666.71924.peg.2028 (98) fig|6666666.72094.peg.3740 (99) fig|1440056.4.peg.41 (98)
GroEL encoding gene groL CD630_01940 yes, proteome fig|6666666.71923.peg.3095 (100) fig|6666666.71924.peg.2995 (99) fig|6666666.72094.peg.3129 (100) fig|1440056.4.peg.3232 (99)
Cell surface protein cwp66 CD630_27890 no fig|6666666.71923.peg.2085 (60) fig|6666666.71924.peg.3721 (78) fig|6666666.72094.peg.2462 (77) fig|1440056.4.peg.2669 (79)
Protease cwp84 CD630_27870 no fig|6666666.71923.peg.2087 (98) fig|6666666.71924.peg.3719 (99) fig|6666666.72094.peg.2460 (99) fig|1440056.4.peg.2671 (99)
Adhesin (LPXTG) CD630_28310 no fig|6666666.71923.peg.2041 (99) fig|6666666.71924.peg.3767 (94) fig|6666666.72094.peg.2504 (98) fig|1440056.4.peg.2625 (94)
Cell wall binding protein encoding cwp2 CD630_27910 yes, proteome fig|6666666.71923.peg.2083 (98) fig|6666666.71924.peg.3723 (99) fig|6666666.72094.peg.2464 (99) fig|1440056.4.peg.2667 (99)
Cell wall binding protein encoding cwp12 CD630_27940 no fig|6666666.71923.peg.2080 (65)* fig|6666666.71924.peg.3726 (98) fig|6666666.72094.peg.2467 (95) fig|1440056.4.peg.2664 (94)
Cell wall binding protein encoding cwp11 CD630_27950 yes, proteome fig|6666666.71923.peg.2079 (98) fig|6666666.71924.peg.3727 (99) fig|6666666.72094.peg.2468 (99) fig|1440056.4.peg.2663 (99)
Cell wall binding protein encoding cwp9 CD630_27980 no fig|6666666.71923.peg.2076 (99) fig|6666666.71924.peg.3730 (99) fig|6666666.72094.peg.2471 (99) fig|1440056.4.peg.2660 (99)
Cell wall hydrolase (LPXTG) CD630_01830 no fig|6666666.71923.peg.3084 (97)* fig|6666666.71924.peg.2984 (99) fig|6666666.72094.peg.3118 (100) fig|1440056.4.peg.3243 (99)
Cell wall binding protein encoding cwp25
gene
CD630_08440 no fig|6666666.71923.peg.2189 (100) fig|6666666.71924.peg.3292 (97) fig|6666666.72094.peg.2128 (99) fig|1440056.4.peg.522 (97)
N-acetylmuramoyl-L-analini amidase
encoding cwp16
CD630_10350 no fig|6666666.71923.peg.1 (99) fig|6666666.71924.peg.3716 (65)* fig|6666666.72094.peg.1495 (99) fig|1440056.4.peg.1845 (98)
Cell wall hydrolase encoding gene
(invasin)
CD630_27680 no fig|6666666.71923.peg.2107 (99) fig|6666666.71924.peg.3700 (99) fig|6666666.72094.peg.2441 (99) fig|1440056.4.peg.2690 (99)
Polysaccharide de-acetylase CD630_15220 yes, RNAseq
and proteome
fig|6666666.71923.peg.489 (100) fig|6666666.71924.peg.291 (99) fig|6666666.72094.peg.3592 (100) fig|1440056.4.peg.1197 (99)
LmbE-like deacetylase encoding gene CD630_27900 no fig|6666666.71923.peg.2084 (93) fig|6666666.71924.peg.3722 (100) fig|6666666.72094.peg.2463 (100) fig|1440056.4.peg.2668 (97)
Invasin/Sh3 domain containing surface
protein
CD630_11350 no fig|6666666.71923.peg.77 (100) fig|6666666.71924.peg.1641 (98) fig|6666666.72094.peg.2849 (99) fig|1440056.4.peg.320 (98)
Cell wall hydrolase/Invasin associated
protein
CD630_24020 fig|6666666.71923.peg.2730 (100) fig|6666666.71924.peg.2779 (98) fig|6666666.72094.peg.2094 (99) fig|1440056.4.peg.3691 (99)
Autolysin acd gene homolog/mannosyl-
glycoprotein endo neta N acetylglucosamine
CD630_13040 no fig|6666666.71923.peg.256 (100) fig|6666666.71924.peg.1460 (98) fig|6666666.72094.peg.3031 (99) fig|1440056.4.peg.158 (98)
Protease/Serine protease, HrtA family CD630_32840 no fig|6666666.71923.peg.1608 (100) fig|6666666.71924.peg.3459 (99) fig|6666666.72094.peg.64 (100) fig|1440056.4.peg.2801 (99)
Intracellular serine protease CD630_32540 no fig|6666666.71923.peg.1638 (100) fig|6666666.71924.peg.3426 (99) fig|6666666.72094.peg.94 (99) fig|1440056.4.peg.2834 (99)





fig|6666666.71923.peg.1327 (99) fig|6666666.71924.peg.2513 (99) fig|6666666.72094.peg.1937 (99) fig|1440056.4.peg.1500 (98)
Serine protease precursor/Subtilinase
subfamily
CD630_20000 no fig|6666666.71923.peg.1085 (100) fig|6666666.71924.peg.2267 fig|6666666.72094.peg.1687 (99) fig|1440056.4.peg.2329 (99)
Membrane-associated zinc metalloprotease/
M50 family peptidase
CD630_21290 no fig|6666666.71923.peg.1209 (100) fig|6666666.71924.peg.2404 (99) fig|6666666.72094.peg.1813 (100) fig|1440056.4.peg.1610 (100)
Zinc Protease/M16 family peptidase CD630_26610 yes, proteome fig|6666666.71923.peg.2996 (100) fig|6666666.71924.peg.626 (99) fig|6666666.72094.peg.3677 (100) fig|1440056.4.peg.438 (99)















in C. difficile infection has been extensively studied but
factors that enable C. difficile to efficiently colonise the
human gastrointestinal tract are relatively poorly under-
stood and are not associated with genes encoded on the
PaLoc. It is not known why some toxigenic strains
evolve into dominant hypervirulent clones. Thus, con-
sidering the genetic diversity inherent within the phylo-
genetic structure of C. difficile [14] a sub-population of
toxin-negative strains of C. difficile that are efficient
colonisers of the host gastrointestinal tract may read-
ily acquire the PaLoc and evolve to become future
hypervirulent strains. Several proteins have been sug-
gested to play crucial roles in the colonization of
gastrointestinal epithelium and disease progression
[43, 71, 73, 74, 76–78]. A recent global proteome
study of C. difficile strains CD630 and R20291 has
identified numerous extracellular proteins from cul-
ture supernatants that may contribute to the virulence
attributes of these strains [70].
Our study reinforced the important role played by
phage in the evolution of C. difficile. While PHAST ana-
lysis was useful for identifying phage sequences, the ana-
lysis may not have identified the full extent of lysogenic
phage because our draft genomes remain in multiple
scaffolds. Although the complete sequence of phage
phiC2 was identified in isolates 19.3 and 22.1 the regions
that had significant homology with phiC2 in isolates P29
and H3 were located on different scaffolds. We used a
scaffold tiling approach against the closed genome of a
reference strain to create the input file for PHAST ana-
lysis (PHAST converts the scaffolded genomes into a
concatenated artificial chromosome prior to predicting
the phage content) and as such it remains a possibility
that the partial matches are a consequence of the data
handling process. Phage phiC2 is present in the majority
of human isolates of C. difficile [68]. However, we de-
tected regions of phiC2 in strains P29 and H3 suggesting
that further studies are needed to address issues sur-
rounding the association of phiC2 in C. difficile of
animal origin. We also identified the C. difficile temper-
ate bacteriophage phiCD6356 from the Siphoviridae
family in isolates P29 and H3 but not in our human iso-
lates of C. difficile. Genomes of bacteriophages belong-
ing to the Siphoviridae family range in size from 14 to
50 kb [79, 80] and this broad range may be a reflection
of the stringency governing the amount of DNA that
can be packaged by phiCD6356. In addition to the ac-
quisition of phage-associated genes, a 119.3-kb region
on contig 11 in isolate P29 was also identified in the
course of this analysis. This region is unique to the P29
genome and displayed significant DNA sequence identity
to portions of the CD630 genome. It remains unknown
if the 119.3-kb region exists in C. difficile strains of por-
cine origin. Further analyses with greater numbers of
genomes from both human and animal sources are re-
quired to conclusively address these questions.
Conclusions
Our studies reinforce calls to improve our understanding
of the physiological conditions that promote lateral
transfer of the PaLoc in the gastrointestinal tract [44].
This is important because the conditions that facilitate
movement of fragments of DNA carrying the PaLoc and
their recombination into the chromosome are also con-
ducive to the movement of conjugative transposons that
carry antibiotic resistance genes and putative virulence
factors as independent genetic events [44].
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